JNJ Johnson & Johnson | US4781601046
Financials
Trends
Details
| Breakdown | 31.12.2027 | 31.12.2026 | Change % |
|---|---|---|---|
| Total Revenue | 108.382.105.230 | 101.261.294.740 | 7.03% |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| Operating Expense | -- | -- | -- |
| Selling General and Administrative | -- | -- | -- |
| Research & Development | -- | -- | -- |
| Operating Income | -- | -- | -- |
| Pretax Income | -- | -- | -- |
| Net Income Common Stockholders | -- | -- | -- |
| Basic EPS | 12,83 | 11,68 | 9.91% |
| Diluted EPS | -- | -- | -- |
| Analyst Count | 23 | 23 | 0.00% |
| EBIT | -- | -- | -- |
| EBITDA | -- | -- | -- |